Lumida
/OSG
⌘K
OSG

OSG

OSG
$4.64USD+2.88%+0.13 today

MARKET CAP

207.2M

P/E (TTM)

49.0x

FWD P/E

11.7x

DAY RANGE

$5 – $5

52W RANGE

$4
$10

AI Summary

Stalk
StalkMedium

Despite a longer-term downtrend, the early Stage 1 base produced a clear Momentum Breakout in early May that underpins a bullish medium-term bias. However, price has extended sharply above the 9/21 EMAs into overbought territory, making immediate buying unfavorable. Patience is warranted until a pullback into the rising EMA zone or the prior resistance-turned-support region, where acceptance can be assessed before entry.

  • Q1 2026 revenue rose 92% to $78.5M, with 42% organic gain.
  • Adjusted EBITDA grew fourfold to $25.3M in Q1 2026.
  • Q4 2025 net loss of $30M due to ArmadaCare acquisition expenses.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2025TREND
Sales, Adj.$418.7M$359.1M$466.8M$451.9M$251.2M
YoY %+17.8%-14.2%+30.0%-3.2%-44.4%
P / Sales0.5x0.5x0.6x0.9x1.5x
EV / Sales2.3x2.4x2.1x2.4x5.7x
Gross Profit, Adj.$216.4M$152.2M$249.7M$257.3M$151.2M
YoY %+7.9%-29.7%+64.1%+3.1%-41.2%
Margin %51.7%42.4%53.5%56.9%60.2%
EV / Gross Profit4.5x5.7x4.0x4.1x9.5x
EBITDA, Adj.$98.9M$39.0M$133.8M$164.1M$-40.4M
YoY %+20.0%-60.6%+243.2%+22.6%-124.6%
Margin %23.6%10.9%28.7%36.3%-16.1%
EV / EBITDA9.9x22.2x7.4x6.5x-35.5x
EBIT$40.4M$-22.8M$63.2M$96.9M$-82.4M
YoY %+34.9%-156.5%+376.9%+53.4%-185.0%
Margin %9.7%-6.4%13.5%21.4%-32.8%
EV / EBIT24.2x-37.9x15.7x11.0x-17.4x
Net Income$30.0M$-46.3M$26.6M$62.5M$-279.9M
YoY %+245.9%-254.2%+157.4%+135.1%-548.1%
Net Margin7.2%-12.9%5.7%13.8%-111.4%
EPS (GAAP)$0.33-$0.51$0.29$0.77-$5.93
YoY %+230.0%-254.5%+156.9%+165.5%-870.1%